Avai Bio (AVAI) Other Operating Expenses (2018 - 2025)

Avai Bio has disclosed Other Operating Expenses across 8 years of filings, most recently posting $319655.0 for Q4 2025.

• Other Operating Expenses for Q4 2025 came in at $319655.0, up 89.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $835755.0 (down 32.19% YoY), and the FY2025 annual result was $769457.0, up 11.53% from the prior year.
• Other Operating Expenses came in at $319655.0 for Q4 2025 at Avai Bio, up from $105840.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $603084.0 in Q1 2024 to a low of -$7736.0 in Q3 2022.
• The 5-year median for Other Operating Expenses is $56742.0 (2021), against an average of $125507.8.
• Across the five-year window, Other Operating Expenses soared 1703566.67% in 2021 and tumbled 113.63% in 2022, its largest moves.
• Avai Bio's Other Operating Expenses stood at $153330.0 in 2021, then plunged by 92.97% to $10783.0 in 2022, then jumped by 159.36% to $27967.0 in 2023, then soared by 503.56% to $168797.0 in 2024, then soared by 89.37% to $319655.0 in 2025.
• The last three Other Operating Expenses figures came in at $319655.0 (Q4 2025), $105840.0 (Q3 2025), and $273703.0 (Q2 2025), per Business Quant data.